In the context of MS, which also impacts oligodendroglia and has reduced SCD (as seen in MSA), the application of a SCD inhibitor increased colocalization of myelin basic protein (MBP) and neurofilament and promoted myelination of demyelinated axons in ex vivo mouse brain slices.35 Here, SCD is linked to multiple system atrophy.